Search results for "Thromboprophylaxis"
Virtual glucose monitoring, statins and heart surgery
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2017/08/recent-research.htm
15 Aug 2017
Dalteparin not superior to unfractionated heparin for preventing proximal DVT in the critically ill
The low-molecular-weight heparin dalteparin was not superior to unfractionated heparin for preventing deep venous thrombosis in critically ill patients, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2011/03/30/4.htm
30 Mar 2011
Getting the most from advanced practice providers
Hospitalists team up with nurse practitioners and physician assistants.
https://acphospitalist.acponline.org/archives/2016/12/advanced-practice-providers.htm
15 Dec 2016
Intermittent pneumatic compression helps reduce VTE risk
Intermittent pneumatic compression (IPC) to the lower limbs can reduce venous thromboembolism (VTE) risk in hospitalized patients and is especially effective when combined with pharmacologic thromboprophylaxis, a new meta-analysis found.
https://acphospitalist.acponline.org/weekly/archives/2013/07/24/1.htm
24 Jul 2013
Heart failure may be independent risk factor for VTE
Researchers performed a systematic review and meta-analysis to examine the absolute and relative risks (RRs) for venous thromboembolism after hospital admission in patients with heart failure, finding a pooled RR of 1.51 compared to other hospitalized patients.
https://acphospitalist.acponline.org/weekly/archives/2015/12/16/3.htm
16 Dec 2015
Recent Research
Ambulatory ECG monitoring after stroke, benefit of ventilator bundle components, alteplase and long-term survival after ischemic stroke, and more.
https://acphospitalist.acponline.org/archives/2016/11/recent-research.htm
15 Nov 2016
Risk for DVT, PE, bleeding after COVID-19, but low long-term VTE recurrence risk
One study found increased risk for deep venous thrombosis (DVT) for up to three months after COVID-19, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while another showed low rates of venous thromboembolism (VTE) recurrence in the year after infection.
https://acphospitalist.acponline.org/archives/2022/04/13/free/risk-for-dvt-pe-bleeding-seen-after-covid-19-long-term-risk-for-vte-recurrence-may-be-low.htm
13 Apr 2022
Factor Xa inhibitors lower DVT risk in hip, knee replacement
For patients undergoing total hip or knee replacement, lower doses of oral direct factor Xa inhibitors reduce the risk of symptomatic deep venous thrombosis (DVT) compared to low-molecular-weight heparin, a review found.
https://acphospitalist.acponline.org/weekly/archives/2012/03/21/1.htm
21 Mar 2012
Reducing HIT by removing the culprit
An “avoid heparin” policy yields benefit.
https://acphospitalist.acponline.org/archives/2017/02/success-story-heparin-induced-thrombocytopenia.htm
15 Feb 2017
Journal watch: Recent studies of note
Recent studies of note.
https://acphospitalist.acponline.org/archives/2010/03/jw.htm
15 Mar 2010